Page last updated: 2024-09-03

omega-n-methylarginine and Psoriasis

omega-n-methylarginine has been researched along with Psoriasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Copeland, P; Ormerod, AD; Shah, SA	1

Trials

1 trial(s) available for omega-n-methylarginine and Psoriasis

Article	Year
Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. The British journal of dermatology, 2000, Volume: 142, Issue:5 Topics: Adult; Aged; Biological Availability; CD4-Positive T-Lymphocytes; Cell Division; Double-Blind Method; Endothelium; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Psoriasis; Regional Blood Flow; Treatment Outcome	2000

Article

Year

Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis.

The British journal of dermatology, 2000, Volume: 142, Issue:5

Topics: Adult; Aged; Biological Availability; CD4-Positive T-Lymphocytes; Cell Division; Double-Blind Method; Endothelium; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Psoriasis; Regional Blood Flow; Treatment Outcome

2000